Primary Care Clinics in Odessa, MO Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 Odessa Medical Group Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 316 West 40 Hwy, Odessa, MO 64076 Phone: 816-633-5774 Fax: 816-633-5936 |
Bradley L Zink Do Family Medicine Medicare: Medicare Enrolled Practice Location: 408 N. 4th St, Suite B, Odessa, MO 64076 Phone: 816-230-8777 Fax: 816-230-8855 |
Serc Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 211 N 2nd St, Odessa, MO 64076 Phone: 816-230-3280 Fax: 816-230-3230 |
Compass Health, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 1278 W Us Highway 40, Odessa, MO 64076 Phone: 816-633-5921 |
Odessa Eye Care Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 201 N 2nd St Ste C, Odessa, MO 64076 Phone: 816-230-5321 Fax: 816-565-2288 |
Live Well Community Health Center Odessa Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 607 S 3rd St, Odessa, MO 64076 Phone: 877-344-3572 Fax: 866-288-4492 |
News Archive
Doctors propose ways to reduce obstetrical complications in women with endometriosis
A team of doctors from RUDN University with their Italian colleagues had studied the data of existing studies on the effect of endometriosis on pregnancy and childbirth and suggested ways to reduce obstetrical complications in women with this condition.
Xenogenics acquires Ideal BioStent assets
MultiCell Technologies, Inc. and its majority owned subsidiary, Xenogenics Corporation, are pleased to announce the acquisition of the Ideal™ BioStent assets by Xenogenics Corporation from investment funds managed by Western Technology Investment and Silicon Valley Bank. Xenogenics Corporation also entered into a worldwide exclusive license with Rutgers University for rights to certain intellectual property related to the Ideal™ BioStent.
Autism experts, parents and professionals to attend ARI's Defeat Autism Now! Conference
The Centers for Disease Control and Prevention recently released new estimates that one in every 110 children (1 in 70 boys) is diagnosed with autism. Autism has become more common in our children than cancer, diabetes and AIDS combined. Autism affects children from all socioeconomic and ethnic backgrounds and places a tremendous economic burden on affected families and society at large, costing up to $3.2 million per child for a lifetime of care and over $35 billion in annual societal cost.
BIOGUARD wound dressings with Quick-Med's NIMBUS antimicrobial technology to be sold by Medline Industries
Quick-Med Technologies, Inc. announced today that its licensee, Derma Sciences, Inc., has entered into an exclusive distribution agreement with Medline Industries whereby Medline will market and sell BIOGUARD™ wound dressings with Quick-Med's proprietary NIMBUS antimicrobial technology. The agreement covers the acute care segment of the health care market, which includes nearly 6,000 hospitals in the United States plus surgery centers, wound care centers, and other associated health care facilities. Sales under this new agreement are expected to start later this month.
› Verified 2 days ago